<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Postgrad Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Postgrad Med</journal-id>
      <journal-id journal-id-type="publisher-id">JPGM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Postgraduate Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-3859</issn>
      <issn pub-type="epub">0972-2823</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25766349</article-id>
      <article-id pub-id-type="pmc">4943429</article-id>
      <article-id pub-id-type="publisher-id">JPGM-61-126</article-id>
      <article-id pub-id-type="doi">10.4103/0022-3859.150897</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Primary renal primitive neuroectodermal tumor</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Goel</surname>
            <given-names>V</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Talwar</surname>
            <given-names>V</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dodagoudar</surname>
            <given-names>C</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Singh</surname>
            <given-names>S</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sharma</surname>
            <given-names>A</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patnaik</surname>
            <given-names>N</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">2</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India</aff>
      <aff id="aff2"><label>1</label>Department of Pathology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India</aff>
      <aff id="aff3"><label>2</label>Department of Pathology, University College of Medical Sciences and Guru Tegh Bahadur Hospital, New Delhi, India</aff>
      <author-notes>
        <corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Varun Goel, E-mail: <email xlink:href="goelvarundoc@gmail.com">goelvarundoc@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>61</volume>
      <issue>2</issue>
      <fpage>126</fpage>
      <lpage>128</lpage>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>09</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>1</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; 2015 Journal of Postgraduate Medicine</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Primitive Neuroectodermal Tumor of the kidney is a rare entity. Very few cases of primary renal PNET have been reported to date. Most literature about rPNET is isolated case reports. We report a case of rPNET in a 39-year-old male with a pre-operative diagnosis of renal cell carcinoma with renal vein thrombosis. The patient underwent radical nephrectomy with thrombolectomy, and histopathological examination revealed a highly aggressive tumor composed of monotonous sheets of round cells. Tumor cells were positive for CD 99 and FLI-1, hence confirming the diagnosis of Primitive Neuroectodermal Tumor. Post-surgery, patient was given VAC/IE-based adjuvant chemotherapy. In view of highly aggressive nature of this tumor, prompt diagnosis and imparting effective chemotherapy regimen to the patient is required, and it is important to differentiate PNET from other small round-cell tumors because of different therapeutic approach.</p>
      </abstract>
      <kwd-group>
        <title>KEY WORDS</title>
        <kwd>Chemotherapy</kwd>
        <kwd>immunohistochemistry</kwd>
        <kwd>kidney</kwd>
        <kwd>primitive neuroectodermal tumor</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-1">
      <title>Introduction</title>
      <p>Primitive Neuroectodermal Tumor (PNET), a highly aggressive tumor of the kidney is a rare malignancy with only few cases being reported in literature.[<xref rid="ref1" ref-type="bibr">1</xref>] It generally occurs in adolescents and young adults with isolated pediatric cases.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref>] Boys and men are more likely to suffer rPNET (renal PNET), and the sex ratio (male: female) is about 3:1.[<xref rid="ref4" ref-type="bibr">4</xref>] It usually presents at an advanced stage, with distant metastasis and is associated with a poor prognosis. We report in this paper, a case of primary renal PNET in a young male.</p>
    </sec>
    <sec id="sec1-2">
      <title>Case Report</title>
      <p>A 39-year-old male presented with complaints of hematuria and heaviness in the right flank since 15 days. Physical examination revealed a soft lump in the right hypochondrium. Ultrasound examination of the abdomen showed an irregular cystic structure in the right kidney at lower pole with few internal echoes. Size of the mass lesion was 25 &#xD7; 30 mm. CT scan of the abdomen demonstrated a large significantly enhancing right renal lower polar mass with necrosis with thrombosis in right renal vein. On the basis of these clinico-radiological findings, diagnosis of right side renal cell cancer was made, and right radical nephrectomy with thrombolectomy was performed. Gross examination revealed a friable, grayish-white, lobulated mass (7 &#xD7; 5 cm) with multiple foci of hemorrhage and necrosis. The mass extended from mid to lower pole of the right kidney and infiltrated into the renal pelvis and was limited to the renal capsule The renal vein and ureter were free of the tumor. There was a thrombus inside the renal vein, which was not adherent to intima of renal vein. No lymph nodes were dissected from aortocaval region. Microscopically, the tumor was composed of monotonous sheets of round cells with scant cytoplasm, hyperchromatic vesicular nuclei, coarse chromatin and few conspicuous nucleoli, transverse by thin fibrous bands infiltrating and entrapping the renal glomeruli and tubules [<xref ref-type="fig" rid="F1">Figure 1</xref>]. Brisk mitosis and apoptosis was noted. Areas of necrosis were present. Lympho-vascular embolization was present. No extension into the peri-renal fat was seen. On immunohistochemistry, the tumor cells were positive for CD99 [<xref ref-type="fig" rid="F2">Figure 2a</xref>], FLI-1 [<xref ref-type="fig" rid="F2">Figure 2b</xref>], NSE [<xref ref-type="fig" rid="F2">Figure 2c</xref>], and synaptophysin [<xref ref-type="fig" rid="F2">Figure 2d</xref>], but negative for desmin, CK, EMA, and LCA. A diagnosis of PNET was made based on the above findings, and patient was started on VAC (vincristine, adriamycin, and cyclophosphamide) alternating with IE (ifosfamide and etoposide)-based adjuvant chemotherapy regimen which he tolerated well. After 6 cycles of chemotherapy, a PET scan showed absence of any metabolically active focal uptake in whole body. Bone marrow aspiration and biopsy was done, which revealed uninvolved bone marrow. Chemotherapy with VAC (vincristine, actinomycin D, and cyclophosphamide) alternating with IE (ifosfamide and etoposide) for a year was planned.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Section showing malignant round cells arranged in pattern sheets infiltrating and entrapping the renal glomeruli and tubules {<xref ref-type="fig" rid="F1">Figure 1a</xref>: H&amp;E; &#xD7;100, <xref ref-type="fig" rid="F1">Figure 1b</xref>: H&amp;E; &#xD7;200}</p>
        </caption>
        <graphic xlink:href="JPGM-61-126-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>(a) The tumor cells express membranous expression of CD99 {DAB; &#xD7;200} (b) The tumor cells express nuclear positivity for FLI-1{DAB; &#xD7;200} (c) The tumor cells express cytoplasmic positivity for neuron-specific enolase (NSE) {DAB; &#xD7;200} (d) The tumor cells expressing cytoplasmic positivity for synaptophysin {DAB; &#xD7;200}</p>
        </caption>
        <graphic xlink:href="JPGM-61-126-g002"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="sec1-3">
      <title>Discussion</title>
      <p>The Primitive Neuroectodermal Tumor (PNET), was first recognized by Arthur Purdy Stout in 1918, and is a member of the family of &#x201C;small round-cell tumors.&#x201D;[<xref rid="ref5" ref-type="bibr">5</xref>] PNET arising in the kidney was first reported by Mor in 1994.[<xref rid="ref6" ref-type="bibr">6</xref>] Primitive Neuroectodermal Tumors occurs preferentially in the soft-tissues of the paravertebral region and chest wall, less frequently in extremities, with a slight male predominance. rPNET appears to be an unique clinical entity that behaves more aggressively than PNET arising at other sites.[<xref rid="ref7" ref-type="bibr">7</xref>]</p>
      <p>The presenting symptoms and images of rPNET are non-specific and similar to other renal tumors. rPNET show a male predominance with 85% cases being diagnosed during the second to fourth decade. It is an aggressive tumor that tends to recur locally and to metastasize to lymph nodes, lung, liver, bone, and bone marrow, which entail a worse prognosis.[<xref rid="ref8" ref-type="bibr">8</xref>]</p>
      <p>The differential diagnosis of rPNET includes other small round cell tumors like neuroblastoma, adult nephroblastoma, malignant lymphoma, rhabdoid tumor, small cell carcinoma and monophasic, poorly differentiated, round cell variant of synovial sarcoma, carcinoid, rhabdomyosarcoma, clear cell sarcoma of the kidney, the small cell variant of osteosarcoma, and desmoplastic small round cell tumor.[<xref rid="ref9" ref-type="bibr">9</xref>]</p>
      <p>Grossly, rPNET are typically very large tumors with about 65% measuring &gt;10 cm in diameter.[<xref rid="ref10" ref-type="bibr">10</xref>] They tend to be grayish in color, encapsulated, and contain focal areas of hemorrhage or necrosis. Microscopically, the tumor is composed of sheets of round cells; individual cells have a round nucleus with a distinct nuclear membrane, fine powdery chromatin, and 1 or 2 small nucleoli. The cytoplasm is ill-defined, scanty, usually PAS-positive, and mitosis are variable. Perivascular pseudo rosettes and Homer-Wright rosettes are common.</p>
      <p>To better address the diagnosis, an immunohistochemical analysis is necessary. Immunohistochemical markers to be used to confirm diagnosis are cytokeratin (for nephroblastoma, small cell carcinoma, and synovial sarcoma), LCA (for Lymphoma), NSE/chromogranin A (for neuroblastoma), and CD-99 for PNET. CD99 (the product of MIC2 gene) greatly aids in recognizing the ES/PNET family of tumors.[<xref rid="ref11" ref-type="bibr">11</xref>] Many PNET also stain for neural markers, including NSE, Leu-7, S-100 protein, synaptophysin, and PGP9.5.[<xref rid="ref12" ref-type="bibr">12</xref>]</p>
      <p>The most frequent translocation in PNET is t(11;22)(q24;q12), detected in approximately 90% of cases, resulting in EWS-FLI fusion gene. Monoclonal antibodies to FLI1 can be used to detect these tumors.[<xref rid="ref13" ref-type="bibr">13</xref>]</p>
      <p>The 5-year disease-free survival rate of rPNET is about 45% to 55%.[<xref rid="ref14" ref-type="bibr">14</xref>] The overall survival in patients who had localized rPENT was longer than that in the patients who had rPENT with regional nodes or distant metastases.[<xref rid="ref15" ref-type="bibr">15</xref>] The preferred treatment for rPENT is surgical resection associated with chemotherapy and radiotherapy treatment. The role of radiotherapy is not clear, but it may be advocated in locally advanced disease and involvement of Gerota's fascia.[<xref rid="ref15" ref-type="bibr">15</xref>] Post-operative chemotherapy for rPENT is usually used and can improve the prognosis of rPNET.[<xref rid="ref7" ref-type="bibr">7</xref>] The most commonly used chemotherapeutics are adriamycin, etoposide, dactinomycin, vincristine, cyclophosphamide, and ifosfamide.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref14" ref-type="bibr">14</xref>] A multimodality management is recommended.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Funahashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hattori</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mizutani</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yoshino</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsukawa</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ewing's sarcoma/primitive neuroectodermal tumor of the kidney</article-title>
          <source>AktuelleUrol</source>
          <year>2009</year>
          <volume>40</volume>
          <fpage>247</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Citak</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Oguz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Karadeniz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Okur</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Akyurek</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Primitive neuroectodermal tumor of the kidney in a child</article-title>
          <source>Pediatr Hematol Oncol</source>
          <year>2009</year>
          <volume>26</volume>
          <fpage>481</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">19863203</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popov</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Sebire</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Pritchard-Jones</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vujani&#x107;</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Renal tumors in children aged 10-16 years: A report from the United Kingdom Children's Cancer and Leukaemia Group</article-title>
          <source>Pediatr Dev Pathol</source>
          <year>2011</year>
          <volume>14</volume>
          <fpage>189</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">21054158</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez-Galindo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Marina</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Parham</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Bodner</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>Is primitive neuroectodermal tumor of the kidney a distinct entity?</article-title>
          <source>Cancer</source>
          <year>1997</year>
          <volume>79</volume>
          <fpage>2243</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">9179073</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stout</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>A tumor of the ulnar nerve</article-title>
          <source>Proc NY Pathol Soc</source>
          <year>1918</year>
          <volume>18</volume>
          <fpage>2</fpage>
          <lpage>12</lpage>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mor</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nass</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Raviv</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Neumann</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nativ</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Goldwasser</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Malignant peripheral primitive neuroectodermal tumor (PNET) of the kidney</article-title>
          <source>Med PediatrOncol</source>
          <year>1994</year>
          <volume>23</volume>
          <fpage>437</fpage>
          <lpage>40</lpage>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohgaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Horiuchi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mizutani</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin</article-title>
          <source>Int J ClinOncol</source>
          <year>2010</year>
          <volume>15</volume>
          <fpage>210</fpage>
          <lpage>4</lpage>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aghili</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rafiei</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mojahed</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zare</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Renal primitive neuroectodermal tumor: Does age at diagnosis impact outcomes?</article-title>
          <source>Rare Tumors</source>
          <year>2012</year>
          <volume>4</volume>
          <fpage>e15</fpage>
          <pub-id pub-id-type="pmid">22532913</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedrichs</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Vorreuther</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Poremba</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schafer</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>B&#xF6;cking</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Buettner</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primitive neuroectodermal tumor (PNET) inthe differential diagnosis of malignant kidney tumors</article-title>
          <source>Pathol Res Pract</source>
          <year>2002</year>
          <volume>198</volume>
          <fpage>563</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">12390000</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Eble</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Sauter</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Sesterhenn</surname>
              <given-names>IA</given-names>
            </name>
          </person-group>
          <article-title>World Health Organisation classification of tumors. Pathology and genetics of tumors of the urinary system and male genital organs</article-title>
          <year>2004</year>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC Press</publisher-name>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Folpe</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Goldblum</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Shehata</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Dei Tos</surname>
              <given-names>AP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Morphologic and immunophenotypic diversity in Ewing family tumors: A study of 66 genetically confirmed cases</article-title>
          <source>Am J SurgPathol</source>
          <year>2005</year>
          <volume>29</volume>
          <fpage>1025</fpage>
          <lpage>33</lpage>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carter</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Al-Sams</surname>
              <given-names>SZ</given-names>
            </name>
            <name>
              <surname>Corbett</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Clinton</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumors in children</article-title>
          <source>Histopathology</source>
          <year>1990</year>
          <volume>16</volume>
          <fpage>461</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">2163356</pub-id>
        </element-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rossi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Orvieto</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Furlanetto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Laurino</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ninfo</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Dei Tos</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody</article-title>
          <source>ModPathol</source>
          <year>2004</year>
          <volume>17</volume>
          <fpage>547</fpage>
          <lpage>52</lpage>
        </element-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Habermann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Benesch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schips</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pummer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ratschek</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Uggowitzer</surname>
              <given-names>MM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Findings and clinical course of a localized primitive peripheral neuroectodermal tumor of the kidney</article-title>
          <source>UrolInt</source>
          <year>2003</year>
          <volume>71</volume>
          <fpage>319</fpage>
          <lpage>21</lpage>
        </element-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thyavihally</surname>
              <given-names>YB</given-names>
            </name>
            <name>
              <surname>Tongaonkar</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kurkure</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Amare</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Muckaden</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primitive neuroectodermal tumor of the kidney: A single institute series of 16 patients</article-title>
          <source>Urology</source>
          <year>2008</year>
          <volume>71</volume>
          <fpage>292</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">18308106</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
